Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,643,467
+$587,715 QoQ
Shares Held
22,221
+7.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#1,530
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McAdam, LLC holds $23,291,732 across 9 Drug Manufacturers - General names. JNJ ranks #1 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
22,221 | $5,643,467 | |
| 2 | LLY |
ELI LILLY & Co
|
4,144 | $4,970,438 | |
| 3 | ABBV |
AbbVie Inc.
|
17,535 | $4,412,507 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,372 | $3,260,302 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
25,513 | $3,223,312 | |
| 6 | PFE |
Pfizer Inc
|
27,456 | $661,140 | |
| 7 | AMGN |
Amgen Inc
|
1,375 | $497,915 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,403 | $368,940 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,643,467 | 22,221 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $5,055,752 | 20,683 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,563,714 | 7,556 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,386,756 | 7,479 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,243,690 | 8,142 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,156,899 | 6,976 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $1,179,665 | 8,157 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,235,059 | 7,621 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $925,777 | 6,334 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $975,399 | 6,166 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $936,051 | 5,972 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $956,149 | 6,139 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,014,141 | 6,127 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,251,005 | 8,071 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,124,200 | 6,364 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,294,464 | 7,924 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,158,962 | 6,529 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,165,287 | 6,575 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $1,088,689 | 6,364 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $943,967 | 5,845 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $1,036,049 | 6,289 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $923,318 | 5,618 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $833,327 | 5,295 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $971,293 | 6,524 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $947,986 | 6,741 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $874,112 | 6,666 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||